drugset / Trial / NCT01140217

Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception

NCT01140217

Phase 3 Completed 1659 enrolled Watson Pharmaceuticals
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether NEA TDS is effective in the prevention of pregnancy. The safety of this product will also be evaluated.

Timeline

Start
2010-05
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Norethindrone Unknown Other

Indications

No indication recorded.